| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2016 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOOKING HOLDINGS INC | 20 | Q3 2023 | 1.5% |
| EURONET WORLDWIDE INC | 18 | Q3 2023 | 0.6% |
| REPLIGEN CORP | 17 | Q3 2023 | 2.3% |
| SAREPTA THERAPEUTICS INC | 16 | Q4 2022 | 5.2% |
| NUTANIX INC | 16 | Q4 2022 | 2.9% |
| EVOLENT HEALTH INC | 16 | Q3 2023 | 1.4% |
| DEXCOM INC | 15 | Q2 2023 | 10.3% |
| PTC THERAPEUTICS INC | 15 | Q2 2022 | 1.3% |
| TILRAY INC | 15 | Q2 2023 | 0.9% |
| BILIBILI INC | 14 | Q3 2023 | 7.3% |
View DeepCurrents Investment Group LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View DeepCurrents Investment Group LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.